1 study on Somatostatin pathway mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**GHRP-2's secretagog efficacy is uniquely insensitive to the hormonal and metabolic factors that blunt GHRH-driven GH release**, including visceral adiposity and the IGF-1 / IGFBP axis. For clinicians and researchers…